Corrigendum to “enhanced chemo-immunotherapy against melanoma by inhibition of cholesterol esterification in CD8+ T cells” [nanomedicine: nanotechnology, biology, and medicine 14 (2018) 2541–2550]

IF 4.6 2区医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL

Nanomedicine : nanotechnology, biology, and medicine Pub Date : 2025-06-05 DOI:10.1016/j.nano.2025.102833

Man Li PhD, Yuting Yang PhD, Jiaojie Wei Master of Science, Xingli Cun PhD, Zhengze Lu PhD, Yue Qiu PhD, Zhirong Zhang PhD, Qin He PhD

引用次数: 0

查看原文本刊更多论文

“通过抑制CD8+ T细胞中的胆固醇酯化来增强抗黑色素瘤的化学免疫疗法”的更正[纳米医学：纳米技术，生物学和医学14 (2018)2541-2550]

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nanomedicine : nanotechnology, biology, and medicine 工程技术-纳米科技

CiteScore

11.10

自引率

0.00%

发文量

133

审稿时长

42 days

期刊介绍： The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine. Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.